---
title: "Virtue trial to compare sirolimus and paclitaxel DCB technologies"
date: "2025-04-29T14:14:40.000Z"
publishedDate: "29 avril 2025"
summary: "Orchestra BioMed Holdings has announced that the US Food and Drug Administration (FDA) has approved its investigational device exemption (IDE) amendment to initiate an updated design of the company’s planned Virtue trial. The IDE provides FDA regulatory clearance for Orchestra BioMed to initiate a US pivotal clinical trial comparing its Sirolimus-AngioInfusion balloon—Virtue SAB—to the Agent [&#8230;] The post Virtue trial to compare sirolimus and paclitaxel DCB technologies appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/virtue-trial-to-compare-sirolimus-and-paclitaxel-dcb-technologies/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-04-29-virtue-trial-to-compare-sirolimus-and-paclitaxel-dcb-technologies"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2019/06/OrchestraBiomedVirtueSEB-766x512.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/virtue-trial-to-compare-sirolimus-and-paclitaxel-dcb-technologies/"
---

![Virtue trial to compare sirolimus and paclitaxel DCB technologies](https://cardiovascularnews.com/wp-content/uploads/sites/14/2019/06/OrchestraBiomedVirtueSEB-766x512.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/virtue-trial-to-compare-sirolimus-and-paclitaxel-dcb-technologies/*

## L’essentiel

Orchestra BioMed Holdings has announced that the US Food and Drug Administration (FDA) has approved its investigational device exemption (IDE) amendment to initiate an updated design of the company’s planned Virtue trial. The IDE provides FDA regulatory clearance for Orchestra BioMed to initiate a US pivotal clinical trial comparing its Sirolimus-AngioInfusion balloon—Virtue SAB—to the Agent [&#8230;] The post Virtue trial to compare sirolimus and paclitaxel DCB technologies appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/virtue-trial-to-compare-sirolimus-and-paclitaxel-dcb-technologies/
